SynthesisBMC public health2026
Risk factors for androgenetic alopecia: a systematic review and meta-analysis.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAndrogenetic alopecia (AGA), the most common type of hair loss, is influenced by multiple factors. However, the associations between various risk factors and AGA remain controversial, with no systematic review or meta-analysis comprehensively analyzing these risk factors to date.
methodsPubMed, Embase, and Cochrane databases were searched for observational studies reporting on AGA risk factors from inception through January 5, 2024.
results31 studies involving 11,224 AGA cases and 36,825 controls were included. Family history (presence: odds ratio [OR] 2.72, 95% confidence interval [CI] 1.85–3.99; progression: OR 4.24, 95% CI 2.77–6.49) and smoking (presence: OR 1.46, 95% CI 1.06–2.01; progression: OR 1.60, 95% CI 1.29–1.99) were significantly associated with both presence and progression of AGA. A paternal family history of AGA (OR 2.22, 95% CI 1.59–3.10), insulin resistance (standardized mean difference [SMD] 0.40, 95% CI 0.27–0.53), and high fasting insulin levels (SMD 0.48, 95% CI 0.18–0.78) were also identified as factors that increased the risk of the presence of AGA. Alcohol consumption (OR 1.72, 95% CI 1.28–2.32), insufficient/poor quality sleep (OR 1.36, 95% CI 1.18–1.56), and overweight/obesity (OR 2.31, 95% CI 1.01–5.29) were related to the progression of AGA. Hypertension in men showed a significant correlation with AGA (OR 1.60, 95% CI 1.26–2.04).
conclusionThis meta-analysis identified several risk factors associated with AGA presence and progression, including a family history of AGA, smoking, alcohol consumption, insufficient or poor-quality sleep, overweight/obesity, hypertension in men, insulin resistance, and elevated fasting insulin levels. Future studies should explore the underlying mechanisms linking these factors to AGA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.